Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 419

1.

An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection.

Vickers AJ, Till C, Tangen CM, Lilja H, Thompson IM.

J Natl Cancer Inst. 2011 Mar 16;103(6):462-9. doi: 10.1093/jnci/djr028. Epub 2011 Feb 24.

2.

Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohort.

Vickers AJ, Wolters T, Savage CJ, Cronin AM, O'Brien MF, Pettersson K, Roobol MJ, Aus G, Scardino PT, Hugosson J, Schröder FH, Lilja H.

Eur Urol. 2009 Nov;56(5):753-60. doi: 10.1016/j.eururo.2009.07.047. Epub 2009 Aug 7.

3.

PSA density improves prediction of prostate cancer.

Verma A, St Onge J, Dhillon K, Chorneyko A.

Can J Urol. 2014 Jun;21(3):7312-21.

PMID:
24978363
4.
5.

The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men.

Vedder MM, de Bekker-Grob EW, Lilja HG, Vickers AJ, van Leenders GJ, Steyerberg EW, Roobol MJ.

Eur Urol. 2014 Dec;66(6):1109-15. doi: 10.1016/j.eururo.2014.08.011. Epub 2014 Aug 26.

6.
7.

Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam.

Raaijmakers R, Wildhagen MF, Ito K, Pàez A, de Vries SH, Roobol MJ, Schröder FH.

Urology. 2004 Feb;63(2):316-20.

PMID:
14972481
8.

Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study.

Grönberg H, Adolfsson J, Aly M, Nordström T, Wiklund P, Brandberg Y, Thompson J, Wiklund F, Lindberg J, Clements M, Egevad L, Eklund M.

Lancet Oncol. 2015 Dec;16(16):1667-76. doi: 10.1016/S1470-2045(15)00361-7. Epub 2015 Nov 10.

PMID:
26563502
9.

Incidental carcinoma of the prostate.

van Andel G, Vleeming R, Kurth K, de Reijke TM.

Semin Surg Oncol. 1995 Jan-Feb;11(1):36-45. Review.

PMID:
7538693
11.

Digital rectal examination in primary care is important for early detection of prostate cancer: a retrospective cohort analysis study.

Walsh AL, Considine SW, Thomas AZ, Lynch TH, Manecksha RP.

Br J Gen Pract. 2014 Dec;64(629):e783-7. doi: 10.3399/bjgp14X682861.

12.

Clinical usefulness of free PSA in early detection of prostate cancer.

Luboldt HJ, Swoboda A, Börgermann C, Fornara P, Rübben H; Early Detection Project Group of the German Society of Urology..

Onkologie. 2001 Feb;24(1):33-7.

PMID:
11441278
13.

A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.

Auprich M, Augustin H, Budäus L, Kluth L, Mannweiler S, Shariat SF, Fisch M, Graefen M, Pummer K, Chun FK.

BJU Int. 2012 Jun;109(11):1627-35. doi: 10.1111/j.1464-410X.2011.10584.x. Epub 2011 Sep 21.

14.

Prediagnostic prostate-specific antigen velocity and probability of detecting high-grade prostate cancer.

Krejcarek SC, Chen MH, Renshaw AA, Loffredo M, Sussman B, D'Amico AV.

Urology. 2007 Mar;69(3):515-9.

PMID:
17382156
15.

Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml.

Ornstein DK, Rayford W, Fusaro VA, Conrads TP, Ross SJ, Hitt BA, Wiggins WW, Veenstra TD, Liotta LA, Petricoin EF 3rd.

J Urol. 2004 Oct;172(4 Pt 1):1302-5.

PMID:
15371828
16.

Screening for prostate cancer: the current evidence and guidelines controversy.

Gomella LG, Liu XS, Trabulsi EJ, Kelly WK, Myers R, Showalter T, Dicker A, Wender R.

Can J Urol. 2011 Oct;18(5):5875-83. Review.

17.

Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy.

Sciarra A, Panebianco V, Cattarino S, Busetto GM, De Berardinis E, Ciccariello M, Gentile V, Salciccia S.

BJU Int. 2012 Dec;110(11):1661-5. doi: 10.1111/j.1464-410X.2012.11146.x. Epub 2012 May 4.

19.

Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer.

Fowler JE Jr, Bigler SA, Miles D, Yalkut DA.

J Urol. 2000 Mar;163(3):813-8.

PMID:
10687983
20.

Prostate cancer screening in Tyrol, Austria: experience and results.

Horninger W, Reissigl A, Rogatsch H, Volgger H, Studen M, Klocker H, Bartsch G.

Eur Urol. 1999;35(5-6):523-38.

PMID:
10325519

Supplemental Content

Support Center